9877 — Jenscare Scientific Share News
0.000.00%
Last trade - 00:00- HK$2.84bn
- HK$2.38bn
- CNY90.59m
Brief: Jenscare Scientific Says Lux-Valve Plus Receives Approval From Hong Kong Department Of Health
Brief: Jenscare Scientific Says Lux-Valve Plus Obtains EU MDR CE Certification
Brief: Jenscare Scientific Says Ken-Valve Transcatheter Aortic Valve Replacement System Receives HK Approval
Brief: Jenscare Scientific Posts FY Revenue Of RMB90.6 Million
Brief: Jenscare Scientific Appoints Li Yuanyuan As CFO
Brief: Jenscare Scientific Receives NZ Approval For Ken-Valve And Lux-Valve Plus
Brief: Jenscare Scientific Says Lux-Valve Plus Receives FDA IDE Approval For Pivotal Trial
Brief: Jenscare Scientific Expects Revenue Of RMB90-92 Million For 2025
Brief: Lux-Valve Plus Approved For Hong Kong-Macao Medicine And Equipment Connect
Brief: Jenscare Scientific H1 Net Income RMB -170.3 Million
Brief: Jenscare Scientific Says Ken-Valve Obtained Registration Approval From NMPA China
Brief: Jenscare Scientific Posts FY Capex Of RMB 71.7 Million
Brief: Jenscare Scientific Co Says LV Shiwen Shall Resign As Chief Executive Officer
Brief: Jenscare Scientific Posts H1 Net Loss Of RMB102.3 Mln
Brief: Jenscare Scientific Says Company Agreed To Provide Loan To Hainan Yize Rmb11 Million
Brief: Jenscare Scientific Saus Lux-Valve Registration Application- Not Approved By NMPA
Brief: Jenscare Scientific Posts FY Loss Attributable Of RMB371.7 Mln
Brief: Jenscare Scientific Announces Increase In Shareholding By Chairman, Executive Director
Brief: Jenscare Scientific Says Unusual Price And Trading Volume Movements